SEC Form 4 research

Pelthos Therapeutics Inc. insider transactions

Issuer	Pelthos Therapeutics Inc.
Tickers	PTHS, CHRO
Reporting owners	19
Officers and directors	4
Last public filing	2026-10-06

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-10-06	2026-10-02	Greenleaf Peter	S	797	$21.17	Not reported
2026-10-06	2026-10-02	Friedberg Ezra M	S	558	$20.72	Not reported
2026-10-06	2026-10-02	Pauls Matthew	S	786	$21	Not reported

Officers and directors in the directory

Davis Todd C — 20 qualifying
Francis Knuettel II — 8 qualifying
Friedberg Ezra M — 11 qualifying
Greenleaf Peter — 15 qualifying
Malamut Richard — 3 qualifying
Pauls Matthew — 19 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.